EUCTR2008-001237-95-IT进行中（未招募）不适用
Aprepitant in the prevention of delayed emesis induced by moderately emetogenic chemotherapy (cyclophosphamide + anthracycline) in breast cancer patients: a double-blind randomized study - Aprepitant in the prevention of delayed emesis
AZIENDA OSPEDALIERA S. MARIA DI TERNI0 个研究点目标入组 800 人开始时间: 2009年8月11日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •-patients with breast cancer, receiving for the first time chemotherapy with cyclophosphamide + anthracycline. - patients over 18 years old and those who signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- patients already submitted to chemotherapy - patients receiving chemotherapy on days 2-4 after cyclophosphamide plus anthracyclines - patients with other severe diseases or with predisposition to emesis such as intestinal obstruction, active peptic ulcer, hypercalcemia and brain metastases - contraindications to corticosteroids (i.e.; active peptic ulcer or previous blooding from peptic ulcer submitted to concomitant radiotherapy
研究者
相似试验
进行中（未招募）
不适用
Aprepitant for prevention of acute and delayed nausea and vomiting: a phase III, double-blind, randomized, palcebo-controlled trial in patients receiving a high-emetogenic dose of cyclophosphamide for peripheral blood stem cells harvesting - NDEUCTR2009-017603-28-ITAZIENDA OSPEDALIERA DI PERUGIA
Unknown
3 期
Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells HarvestingNauseaVomitingNCT01088022Azienda Ospedaliera di Perugia120
尚未招募
3 期
Extended dosing of aprepitant to decrease vomiting and nausea that occurs late during chemotherapy for acute myeloid leukaemiaCTRI/2023/03/050220All India Institute of Medical Sciences
尚未招募
3 期
Aprepitant for chemotherapy induced vomiting and nausea during acute myeloid leukemia chemotherapy among children and adolescentsCTRI/2023/06/054320All India Institute of Medical Sciences
终止
3 期
Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer PatientsEmesisNCT00869973S. Maria Hospital, Terni580